🚀 VC round data is live in beta, check it out!

Organo Valuation Multiples

Discover revenue and EBITDA valuation multiples for Organo and similar public comparables like AGL Energy, NorthWestern Energy, COPASA, TAQA Morocco and more.

Organo Overview

About Organo

Organo Corp is a Japan-based company mainly engaged in the water treatment engineering business. The company operates in two business divisions namely water treatment engineering and functional product. Its water treatment engineering business includes manufacturing, delivery and maintenance of pure water systems, ultra-pure water systems and wastewater treatment systems for industries, condensate de mineralizers for power stations, waterworks and sewage treatment systems for the public sector. The functional product business encompasses the sale of standardized water treatment equipment, water treatment chemicals, and food processing materials.


Founded

1941

HQ

Japan

Employees

2.2K

Financials (LTM)

Revenue: $1B
EBITDA: $248M

EV

$4B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Organo Financials

Organo reported last 12-month revenue of $1B and EBITDA of $248M.

In the same LTM period, Organo generated $407M in gross profit, $248M in EBITDA, and $176M in net income.

Revenue (LTM)


Organo P&L

In the most recent fiscal year, Organo reported revenue of $1B and EBITDA of $245M.

Organo expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Organo forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$1BXXX$1BXXXXXXXXX
Gross Profit$407MXXX$348MXXXXXXXXX
Gross Margin36%XXX31%XXXXXXXXX
EBITDA$248MXXX$245MXXXXXXXXX
EBITDA Margin22%XXX22%XXXXXXXXX
EBIT Margin21%XXX19%XXXXXXXXX
Net Profit$176MXXX$165MXXXXXXXXX
Net Margin16%XXX15%XXXXXXXXX
Net Debt——$37MXXXXXXXXX

Financial data powered by Morningstar, Inc.

Organo Stock Performance

Organo has current market cap of $5B, and enterprise value of $4B.

Market Cap Evolution


Organo's stock price is $99.69.

See Organo trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$4B$5B0.3%XXXXXXXXX$3.59

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Organo Valuation Multiples

Organo trades at 4.0x EV/Revenue multiple, and 18.0x EV/EBITDA.

See valuation multiples for Organo and 15K+ public comps

EV / Revenue (LTM)


Organo Financial Valuation Multiples

As of April 19, 2026, Organo has market cap of $5B and EV of $4B.

Equity research analysts estimate Organo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Organo has a P/E ratio of 26.0x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$5BXXX$5BXXXXXXXXX
EV (current)$4BXXX$4BXXXXXXXXX
EV/Revenue4.0xXXX4.0xXXXXXXXXX
EV/EBITDA18.0xXXX18.2xXXXXXXXXX
EV/EBIT18.8xXXX20.9xXXXXXXXXX
EV/Gross Profit10.9xXXX12.8xXXXXXXXXX
P/E26.0xXXX27.8xXXXXXXXXX
EV/FCF38.2xXXX34.3xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Organo Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Organo Margins & Growth Rates

Organo's revenue in the last 12 month grew by 11%.

Organo's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.

Organo's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Organo's rule of X is 48% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Organo and other 15K+ public comps

Organo Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth11%XXX(0%)XXXXXXXXX
EBITDA Margin22%XXX22%XXXXXXXXX
EBITDA Growth15%XXX0%XXXXXXXXX
Rule of 40—XXX33%XXXXXXXXX
Bessemer Rule of X—XXX48%XXXXXXXXX
Revenue per Employee—XXX$0.5MXXXXXXXXX
Opex per Employee—XXX$0.1MXXXXXXXXX
R&D Expenses to Revenue2%XXX2%XXXXXXXXX
Opex to Revenue—XXX14%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Organo Public Comps

See public comps and valuation multiples for other Utilities and Waste & Environmental Services comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
OrganoXXXXXXXXXXXXXXXXXX
AGL EnergyXXXXXXXXXXXXXXXXXX
NorthWestern EnergyXXXXXXXXXXXXXXXXXX
COPASAXXXXXXXXXXXXXXXXXX
TAQA MoroccoXXXXXXXXXXXXXXXXXX
Pampa EnergiaXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

Organo M&A Activity

Organo acquired XXX companies to date.

Last acquisition by Organo was on XXXXXXXX, XXXXX. Organo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by Organo

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

Organo Investment Activity

Organo invested in XXX companies to date.

Organo made its latest investment on XXXXXXXX, XXXXX. Organo invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by Organo

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Organo

When was Organo founded?Organo was founded in 1941.
Where is Organo headquartered?Organo is headquartered in Japan.
How many employees does Organo have?As of today, Organo has over 2K employees.
Is Organo publicly listed?Yes, Organo is a public company listed on Tokyo Stock Exchange.
What is the stock symbol of Organo?Organo trades under 6368 ticker.
When did Organo go public?Organo went public in 1961.
Who are competitors of Organo?Organo main competitors are AGL Energy, NorthWestern Energy, COPASA, TAQA Morocco.
What is the current market cap of Organo?Organo's current market cap is $5B.
What is the current revenue of Organo?Organo's last 12 months revenue is $1B.
What is the current revenue growth of Organo?Organo revenue growth (NTM/LTM) is 11%.
What is the current EV/Revenue multiple of Organo?Current revenue multiple of Organo is 4.0x.
Is Organo profitable?Yes, Organo is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Organo?Organo's last 12 months EBITDA is $248M.
What is Organo's EBITDA margin?Organo's last 12 months EBITDA margin is 22%.
What is the current EV/EBITDA multiple of Organo?Current EBITDA multiple of Organo is 18.0x.
What is the current FCF of Organo?Organo's last 12 months FCF is $117M.
What is Organo's FCF margin?Organo's last 12 months FCF margin is 10%.
What is the current EV/FCF multiple of Organo?Current FCF multiple of Organo is 38.2x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial